Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indeterminate colitis: the real story.

William G Rudolph1, Sonja M S Uthoff, Tracy L McAuliffe

  • 1Digestive Surgery Research Laboratory and the Price Institute of Surgical Research, Department of Surgery, School of Medicine, University of Louisville, Louisville, KY 40292, USA.

Diseases of the Colon and Rectum
|November 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolution of Colorectal Surgery Training.

Clinics in colon and rectal surgery·2026
Same author

EPICERTIN, an engineered variant of cholera toxin B subunit, promotes survival and a pro-remodeling macrophage phenotype for mucosal healing in colitis.

Mucosal immunology·2026
Same author

The Maroon DCR Website Banner: A Cache of Valuable Content-Part II.

Diseases of the colon and rectum·2025
Same author

The Maroon DCR Website Banner: A Cache of Valuable Content-Part I.

Diseases of the colon and rectum·2025
Same author

Transformations.

Diseases of the colon and rectum·2025
Same author

Itaconate and obesity-related hormones promote tumor progression - new insights on metabolic dysfunction in early-onset colon cancer.

Frontiers in immunology·2025
Same journal

Selected Abstracts.

Diseases of the colon and rectum·2026
Same journal

A Penny for Your Thoughts.

Diseases of the colon and rectum·2026
Same journal

June 2026 Translations.

Diseases of the colon and rectum·2026
Same journal

Selected Abstracts.

Diseases of the colon and rectum·2026
Same journal

Recurrence After Rectopexy: Insights From Magnetic Resonance Defecography.

Diseases of the colon and rectum·2026
Same journal

Risk of Metabolic Disease After Right- vs Left-Sided Colectomy for Colon Cancer: A Nationwide Cohort Study.

Diseases of the colon and rectum·2026
See all related articles

Patients with indeterminate colitis undergoing ileal pouch-anal anastomosis have similar long-term functional outcomes to ulcerative colitis patients. Indeterminate colitis patients experienced fewer pouchitis episodes than ulcerative colitis or Crohn's disease patients.

Area of Science:

  • Gastroenterology
  • Colorectal Surgery
  • Inflammatory Bowel Disease

Background:

  • Indeterminate colitis presents diagnostic challenges, with up to 20% of ulcerative colitis patients showing features of both ulcerative colitis and Crohn's disease.
  • Ileal pouch-anal anastomosis (IPAA) is a surgical option for ulcerative colitis, but its outcomes in indeterminate colitis are less understood.

Purpose of the Study:

  • To compare the functional outcomes of IPAA in patients with indeterminate colitis versus ulcerative colitis.
  • To evaluate postoperative complications, pouch function, and medication use in these patient groups.

Main Methods:

  • A retrospective review of 120 IPAA patients with preoperative ulcerative colitis diagnosis.
  • Histological re-evaluation of colectomy specimens by a single pathologist.

Related Experiment Videos

  • Analysis of postoperative complications, pouch function, and medication usage over a mean follow-up of 54 months.

    • Main Results:

    • Indeterminate colitis patients had more postoperative fistulas (26% vs. 10%, P=0.02) but no permanent ileostomies were required, unlike six ulcerative colitis patients.
    • Long-term functional outcomes were similar between indeterminate colitis and ulcerative colitis groups.
    • Indeterminate colitis patients experienced less frequent pouchitis (>3 episodes: 29% vs. 58-72% for UC/CD, P=0.006) and required less maintenance antibiotic therapy (20% vs. 28-64% for UC/CD, P=0.014).

    Conclusions:

    • IPAA in indeterminate colitis patients yields long-term functional results comparable to ulcerative colitis patients and superior to Crohn's disease patients.
    • Despite a higher fistula rate, IPAA is a viable option for indeterminate colitis patients.
    • IPAA should be considered for indeterminate colitis and severe ulcerative colitis cases where differentiation is difficult.